Literature DB >> 14759712

Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes.

A Sidoni1, G Bellezza, A Cavaliere, R Del Sordo, M Scheibel, E Bucciarelli.   

Abstract

The search for single independent prognostic factors in breast cancer has often produced conflicting results. Therefore, prognostic indexes have been compiled by combining several parameters. In this study we compare the Nottingham Prognostic Index (NPI), which is based on traditional prognostic factors (diameter of the neoplasm, lymph node status and histological grade) with the Adelaide Prognostic Index (API), which is based on the tumour diameter and two biological parameters: oestrogen receptors and cell kinetics. We considered 82 cases of breast cancer observed over the period 1987-1990 with a minimum follow-up of 60 months. The NPI gives a better definition of the prognostic profile for each patient. Our results indicate three prognostic groups (good, moderate, unfavourable), which differ with respect to disease-free survival (DFS; P=0.0024) and overall survival (OS; P=0.0033). In contrast, the API scores showed no significant correlation with OS or DFS. The use of prognostic indexes, especially when compiled using traditional parameters, is a useful aid to the clinician, since they can provide a reliable indication of how individual tumours will evolve.

Entities:  

Mesh:

Year:  2004        PMID: 14759712     DOI: 10.1016/j.breast.2003.08.007

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  2 in total

1.  Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index.

Authors:  Mu-Tai Liu; Wen-Tao Huang; Ai-Yih Wang; Chia-Chun Huang; Chao-Yuan Huang; Tung-Hao Chang; Chu-Pin Pi; Hao-Han Yang
Journal:  Support Care Cancer       Date:  2009-11-11       Impact factor: 3.603

2.  Short-Term Prognostic Index for Breast Cancer: NPI or Lpi.

Authors:  V Van Belle; J Decock; W Hendrickx; O Brouckaert; S Pintens; P Moerman; H Wildiers; R Paridaens; M R Christiaens; S Van Huffel; P Neven
Journal:  Patholog Res Int       Date:  2010-12-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.